Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the production of advanced fuels and chemicals through the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into advanced Biorefineries.  Aemetis continues to achieve important milestones that are creating significant value for shareholders. Aemetis is seeking to commercialize the conversion of first generation biodiesel and ethanol plants into integrated production facilities that produce an expanded portfolio of higher value products, such as renewable jet fuel, renewable diesel, renewable chemicals, as well as valuable products from liquefied CO2.

In 2014, Aemetis revenues were $208 million.  The company has over 130 employees worldwide, and is publically traded on the NASDAQ stock market under the symbol AMTX.

Our Keyes ethanol plant recorded record production in 2014 of fuel and wet distiller’s grains, which is sold without drying and used as high value, high protein animal feed by local dairies. The India biorefinery produced 9,000 metric tons of biodiesel, and 2,200 metric tons of refined glycerin, both of which we expect to show significant growth in 2015 due to significant policy improvements in India during the past few months.

Congress created the EB-5 program in 1990 to benefit the US economy and create new jobs by attracting investments from qualified foreign investors who were granted a path to US citizenship through an investment of $500,000 into a qualified project. We view the EB-5 program as a powerful tool with which we can invest in new technologies, expand the production of high value products, and create jobs. We are very pleased about the positive momentum our EB-5 project has gained in the past year, and look forward to expansion of our participation in the future.  To date, Aemetis has received into escrow $24 million through the EB-5 program, and we expect to have the full $36 million fully funded into escrow in 2015, with a substantial portion, or potentially the entire $36 million, approved or actually transferred into Aemetis accounts from the escrow.